Smart Syringe Market Worldwide: Market Dynamics and Trends, Efficiencies Forecast 2025
Smart syringes can be defined as medical devices that are engineered with safety mechanisms to prevent the reuse of syringes and regulate unsafe injection practices. They are equipped with features to avoid needlestick injuries in the person who uses these syringes and prevent transmission of blood-borne diseases such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), and other life-threatening infections. They cater to numerous applications that include vaccination, drug delivery, and blood specimen collection.
The key players operating in the global smart syringe market include Becton, Dickinson and Company, Cardinal Health, Terumo Medical Corporation, B. Braun Melsungen AG, Baxter International, Smiths Group plc, Unilife Corporation, Gerresheimer AG, and Retractable Technologies.
Inc. The other prominent players in the value chain include L.O.M. Medical International, Techcon, Tecan Trading AG, Meissner Filtration Products, Inc., ARxIUM, and Parker Hannifin Corporation.
Learn more : https://www.medgadget.com/2018/12/smart-syringe-market-inclined-to-deliver-positive-growth-results-with-key-players-2025.html
Different types of smart syringes such as auto disable (AD) syringes, passive safety syringes, and active safety syringes, are used depending on the nature of application. The most common types of smart syringes used across all healthcare sectors are active safety syringes, whereas, auto-disable (AD) syringes are used popularly for vaccination. The global smart syringes market was evaluated at $5,737 million in 2017, and is estimated to garner $13,792 million by 2025, registering a CAGR of 10.3% during the forecast period.
Increase in the count of needlestick injuries, high prevalence of blood-borne transmission such as Hepatitis B, C, and HIV through improper injection practices, growth in adoption of safety syringes, and advancements in technology drive the growth of the market. In addition, mandatory recommendation by WHO to switch to smart syringes to ensure safe injection practices is the major factor that boosts the market growth. However, high cost associated with smart syringes, especially passive safety syringes, low awareness in developing economies, and alternative drug delivery methods are expected to impede the market growth.
Product type segment review
Based on product type, the market is segmented into auto disable, active safety, passive safety. Active safety syringes segment accounted for the highest revenue in 2017, owing to established market position. Furthermore, auto disable (AD) syringes are especially used for vaccination purposes and are specifically designed for single use with an internal mechanism that blocks the barrel once used, thereby preventing its further usage.